Through an increased Bax/Bcl-2 ratio, caspase-3 activation, and the loss of mitochondrial potential, ellagic acid sensitizes human CRC cells to 5-FU therapy [353]. This evidence concerns the gene CASP3 and colorectal carcinoma.